These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27523079)

  • 1. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
    Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
    Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
    Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
    Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
    Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
    Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
    Ishiguro Y; Ohmori T; Umemura K; Iizuka M
    Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Needle Granulocyte and Monocyte Apheresis for Ulcerative Colitis: A Retrospective Safety Analysis.
    Imai T; Yamasaki H; Mitsuyama K; Yamaga O; Sugihara G; Kaida Y; Shibata R; Hazama T; Yoshioka S; Torimura T; Fukami K; Yamashita N
    Kurume Med J; 2020 Jul; 66(1):1-7. PubMed ID: 31941846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study.
    Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Sakatani A; Takahashi K; Tanaka K; Serikawa S; Ando K; Kashima S; Muto M; Inaba Y; Moriichi K; Tanabe H; Okumura T; Fujiya M
    J Clin Apher; 2023 Aug; 38(4):406-421. PubMed ID: 36636880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.
    Ruuska T; Wewer V; Lindgren F; Malmborg P; Lindquist M; Marthinsen L; Browaldh L; Casswall T; Kalliomäki M; Grönlund J
    Inflamm Bowel Dis; 2009 Jul; 15(7):1049-54. PubMed ID: 19137602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.
    Saito H; Hanafusa N; Kishikawa J; Noiri E; Sunami E; Ishihara S; Watanabe T; Nangaku M
    J Clin Apher; 2016 Dec; 31(6):584-586. PubMed ID: 26876484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
    Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
    BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus.
    Fukuchi T; Nakase H; Matsuura M; Yoshino T; Toyonaga T; Ohmori K; Ubukata S; Ueda A; Eguchi T; Yamashita H; Ito D; Ashida K
    J Crohns Colitis; 2013 Nov; 7(10):803-11. PubMed ID: 23352104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
    Yokoyama Y; Kawai M; Fukunaga K; Kamikozuru K; Nagase K; Nogami K; Kono T; Ohda Y; Iimuro M; Hida N; Nakamura S; Miwa H; Matsumoto T
    BMC Gastroenterol; 2013 Feb; 13():27. PubMed ID: 23399416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
    Yamamoto T; Umegae S; Matsumoto K
    J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
    Motoya S; Tanaka H; Shibuya T; Osada T; Yamamoto T; Hongo H; Mizuno C; Saito D; Aoyama N; Kobayashi T; Ito H; Tanida S; Nojima M; Kokuma S; Hosoi E
    BMC Gastroenterol; 2019 Nov; 19(1):196. PubMed ID: 31752695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis.
    Hashiguchi K; Takeshima F; Akazawa Y; Matsushima K; Minami H; Machida H; Yamaguchi N; Shiozawa K; Ohba K; Ohnita K; Ichikawa T; Isomoto H; Nakao K
    Digestion; 2015; 91(3):208-17. PubMed ID: 25823500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study.
    Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Takahashi K; Tanaka K; Ando K; Kashima S; Inaba Y; Moriichi K; Tanabe H; Taruishi M; Saitoh Y; Okumura T; Fujiya M
    BMC Gastroenterol; 2021 Aug; 21(1):316. PubMed ID: 34362299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
    Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
    Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis.
    Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Kikuch K; Saniabadi AR
    Digestion; 2004; 70(1):36-44. PubMed ID: 15297776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma Gangrenosum with Ulcerative Colitis Successfully Treated by the Combination of Granulocyte and Monocyte Adsorption Apheresis and Corticosteroids.
    Ohno M; Koyama S; Ohara M; Shimamoto K; Kobayashi Y; Nakamura F; Mitsuru K; Andoh A
    Intern Med; 2016; 55(1):25-30. PubMed ID: 26726081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective granulocyte-monocyte apheresis during induction with vedolizumab in moderate-severe ulcerative colitis: Experience in a tertiary hospital.
    Suárez Ferrer C; Martin-Arranz E; Martín-Arranz MD
    Gastroenterol Hepatol; 2024; 47(7):721-726. PubMed ID: 38219961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.